About Cell Cross
Cell Cross is a Healthcare company. Pharmaceutical marketing and innovation services in India. Its Indian entity Cell Cross Pharmaceuticals Private Limited reported revenue of ₹88.9 Lakh. Cell Cross offers products and services including Pharmaceutical Drugs and Innovation Services. Its focus areas include Biotechnology, Innovation, Research and Pharmaceuticals.
Company details
Cell Cross is recognized as a leading pharmaceutical marketing company in India, where daily efforts are made to promote good health, happiness, and hope through innovative and affordable solutions. The companys mission is driven by values embedded in its business, aiming to deliver breakthrough treatments that address societal healthcare challenges. Affordable pharmaceutical products are extended to as many people as possible, with a focus on quality, integrity, and social responsibility. Core principles like economic sustainability and teamwork are emphasized to foster a better world, while stability testing ensures product reliability across therapeutic areas.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellcross.in
- Social LinkedIn X Facebook
- Legal Name Cell Cross Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 08 Sep, 2021
- Jurisdiction Kangra, Himachal Pradesh, India
- Indian entity revenue₹88.9 Lakh
FY 2025 · +54% YoY
- Indian entity net profit₹64,104
FY 2025 · 1% margin
- Indian entity EBITDA₹1.1 Lakh
FY 2025 · 1% margin
Associated legal entities of Cell Cross
Cell Cross operates through Cell Cross Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cell Cross Pharmaceuticals Private Limited CIN U33119HP2021PTC008805 | Active | 08 Sep 2021 | Kangra, Himachal Pradesh | ₹0.9 Cr | 2 | View details |
Products & Services of Cell Cross
Cell Cross offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Innovation Services.
Pharmaceutical drugs are developed and marketed for various therapeutic areas to provide affordable and innovative solutions that enhance health outcomes.
Innovation services are generated through collaborations with doctors and patients to address market needs and synergies across therapeutic areas.
Board of directors of Cell Cross Pharmaceuticals Private Limited (Cell Cross)
Cell Cross Pharmaceuticals Private Limited is the primary company behind Cell Cross. The board of Cell Cross Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Monika, appointed in 2021.
Financials of Cell Cross
Figures of Cell Cross Pharmaceuticals Private Limited, the primary company behind Cell Cross, for FY 2025. Revenue was ₹88.9 Lakh (+54% year on year). Net profit was ₹64,104 (1% margin). EBITDA was ₹1.1 Lakh (1% margin).
- ₹88.9 LakhRevenue · FY 2025 · +54% YoY
- ₹64,104Net profit · 1% margin
- ₹1.1 LakhEBITDA · 1% margin
- ₹2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Cell Cross Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Cell Cross
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cell Cross
The primary company behind Cell Cross, Cell Cross Pharmaceuticals Private Limited, reported revenue of ₹88.9 Lakh for FY 2025, up 54% year on year.
Cell Cross is recognized as a leading pharmaceutical marketing company in India, where daily efforts are made to promote good health, happiness, and hope through innovative and affordable solutions. The companys mission is driven by values embedded in its business, aiming to deliver breakthrough treatments that address societal healthcare challenges. Affordable pharmaceutical products are extended to as many people as possible, with a focus on quality, integrity, and social responsibility. Core principles like economic sustainability and teamwork are emphasized to foster a better world, while stability testing ensures product reliability across therapeutic areas.
Cell Cross offers Pharmaceutical Drugs and Innovation Services.
Cell Cross operates through Cell Cross Pharmaceuticals Private Limited.
The legal entities of Cell Cross currently have 2 directors, including Monika, Manju.